Corpus Callosum Necrosis with Psychiatric Symptoms Resulting From Chronic Toluene Intoxication/Exposure: A Case Presentation
Keywords:
Toluene intoxication, exposure, corpus callosum, psychiatric symptomsAbstract
Abuse of toluene, which is a neurotoxic substance, causes neurological and psychiatric complications. Similar complications may also be seen in people who are exposed to toluene long term in some industries. Decrease of brain volume and generalised substance changes in brain have been found in imaging studies. Progressive neurological and psychiatric changes have been shown to be due to these changes. In this article, a subject was presented who was exposed to toluene at the workshop for 8 years and has suffered corpus callosum necrosis with progressive psychiatric symptoms.
References
Xiong L, Matthes JD, Li J, ve ark. MR imaging of “spray heads”: toluene abuse via
aerosol paint inhalation. AJNR Am J Neuroradiol, 1993; 14:1195-1199.
Muijser H, Geuskens RB, Hooisma J, ve ark. Behavioral effects of exposure to organic solvents in carpet layers. Neurotoxicol Teratol, 1996; 18: 455-462.
Kamran S, Bakshi R. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology, 1998; 40:519-521.
Morrow LA, Kamis H, Hodgson MJ. Psychiatric symptomatology in persons with organic solvent exposure. J Consult Clin Psychol, 1993; 61:171-174.
Elofsson S, Gamberale F, Hindmarsh T et al. Exposure to organic solvents: a crosssectional epidemiologic investigation on occupationally exposed car and industrial spray painters with special reference to the nervous system. Scan J Work Environ Health 1980; 6:239-273.
Lazar R, Su H, Melen O, Daghestani A. Multifocal central nervous system damage caused by toluene abuse. Neurology, 1983; 33:1337-1340.
Yazıcı MK, Demir B, Tanrıverdi N ve ark. Hamilton anksiyete değerlendirme ölçeği, değerlendiriciler arası güvenirlik ve geçerlik çalışması. Türk Psikiyatri Dergisi 1998; 9:114117.
Çorapcıoğlu A, Aydemir O, Yıldız M ve ark. DSM-IV için yapılandırılmış klinik görüşme formu. Hekimler Yayın Birliği 1999, Ankara.
Eisenberg DP. Neurotoxicity and mechanism of toluene abuse. Einstein Quart J Biol Med 2003; 19:150-159.
Uchino A, Kato A, Yuzuriha T, et al. Comparison between patient characteristics and cranial MR findings in chronic thinner intoxication. Eur Radiol 2002; 12:1338-1341.
Ukai H, Watanabe T, Nakatsuka H, et al. Dosedependent increase in subjective symptoms among toluene exposed workers. Environ Res 1993; 60:274-289.
Tekgül H, Dizdarer G, Yalman O, ve ark. Associated brain abnormalities in patients with corpus callosum anomalies. Turk J Pediatr 1999; 41:173-180.
Taylor M, David AS. Agenesis of the corpus callosum: a United Kingdom series of 56 cases. J Neurol Neurosurg Psychiatry 1998; 64:131-134
Schaumburg HH. Toluene. Experimental and clinical neurotoxicology. New York: Oxford University Press, 2000: 1183-1189.
Gelenberg AJ, Lydiard RB, Rudolph RL et al. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA, 2000 ; 21;283: 3082-3088
Baker EL, Seppalainen AM. Session 3. Human aspects of solvent neurobehavioral effects. Report of the workshop session on clinical and epidemiologicaltopics. Neurotoxicology, 1986; 7:43-56.
Rickert CH, Karger B, Varchmin-Schultheiss K, et al. Neglect-associated fatal Marchiafava-Bignami disease in a non-alcoholic woman. Int J Legal Med 2001;115:90-93.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...